MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617062190 A) filed by Amgen Inc. on May 15, 2026, for Evaluation Of Mrna Transcript Levels Using Ddpcr For Early Pool And Single-Cell Clone Assessment In Cell Line Development.
Inventors include Zah, Eugenia; Cox, Kayley; and Gros, Edwige.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present disclosure relates the field of cell culture technology. It provides a method of facilitating selection of a single cell clone or pools of cells for manufacturing an antigen-binding protein with two to four different antibody chains. The method utilizes ddPCR for the quantification of transcript levels.
Disclaimer: Curated by HT Syndication.
